Back
Vanguard Real Estate Index Fund ETF Vs. MiNK Therapeutics, Inc. Industry Stock Comparison
Sell
47
VNQ
Vanguard Real Estate Index Fund ETF
Last Price:
$88.58
Seasonality Move:
-0.37%
Sell
32
INKT
MiNK Therapeutics, Inc.
Last Price:
$11.68
Seasonality Move:
-18.07%
Sell
47
Vanguard Real Estate Index Fund ETF (VNQ)
is a Sell
Is Vanguard Real Estate Index Fund ETF a Buy, Sell or Hold?
-
The current Vanguard Real Estate Index Fund ETF [VNQ] share price is $88.59. The Score for VNQ is 47, which is 6% below its historic median score of 50, and infers higher risk than normal.
-
VNQ is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
32
MiNK Therapeutics, Inc. (INKT)
is a Sell
Is MiNK Therapeutics, Inc. a Buy, Sell or Hold?
-
The current MiNK Therapeutics, Inc. [INKT] share price is $11.59. The Score for INKT is 32, which is 36% below its historic median score of 50, and infers higher risk than normal.
-
INKT is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
VNQ Stock Price Chart
What is Vanguard Real Estate Index Fund ETF's stock price today?
-
The Vanguard Real Estate Index Fund ETF share price today is $88.59Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and VNQ is experiencing selling pressure, which indicates risk of future bearish movement.
INKT Stock Price Chart
What is MiNK Therapeutics, Inc.'s stock price today?
-
The MiNK Therapeutics, Inc. share price today is $11.59Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and INKT is experiencing slight buying pressure.
VNQ Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 16.71 | Buy |
| Relative Strength Index (14 RSI): | 41.48 | Sell |
| Chaikin Money Flow: | -3625174 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (88.81 - 90.31) | Sell |
| Bollinger Bands (100): | (89.12 - 91.66) | Sell |
INKT Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.19 | Sell |
| Relative Strength Index (14 RSI): | 44.79 | Sell |
| Chaikin Money Flow: | 9780 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (10.89 - 12.35) | Sell |
| Bollinger Bands (100): | (12.23 - 15.15) | Sell |
VNQ Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 89.24 | Sell |
| 20-day SMA: | 89.73 | Sell |
| 50-day SMA: | 89.94 | Sell |
| 200-day SMA: | 89.74 | Sell |
| 8-day EMA: | 47.08 | Buy |
| 20-day EMA: | 23.07 | Buy |
| 50-day EMA: | 10.06 | Buy |
| 200-day EMA: | 2.63 | Buy |
INKT Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 12.09 | Sell |
| 20-day SMA: | 11.62 | Sell |
| 50-day SMA: | 12.8 | Sell |
| 200-day SMA: | 11.89 | Sell |
| 8-day EMA: | 11.86 | Sell |
| 20-day EMA: | 11.96 | Sell |
| 50-day EMA: | 12.6 | Sell |
| 200-day EMA: | 12.22 | Sell |
Vanguard Real Estate Index Fund ETF Earnings Growth & VNQ Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
MiNK Therapeutics, Inc. Earnings Growth & INKT Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.14 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.40 per share, and a decrease next year of $0.82 per share.
Vanguard Real Estate Index Fund ETF Technical Analysis
| Dec 8 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 15 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 08 | 09 | 10 | 11 | 12 | 15 | 16 | 17 | 18 | 19 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
MiNK Therapeutics, Inc. Technical Analysis
| Dec 8 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 15 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 08 | 09 | 10 | 11 | 12 | 15 | 16 | 17 | 18 | 19 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||